|
|
|
|
|
Correlation analysis of platelet-to-lymphocyte ratio and recent major adverse cardiac and cerebrovascular events in patients with severe heart failure |
Huang Zong-yin |
Department of Emergency, People′s Hospital of Lanling County, Linyi 277700, China |
|
|
Abstract Objective: To investigate the correlation of platelet-to-lymphocyte ratio (PLR) and recent major adverse cardiac and cerebrovascular events (MACCE) in patients with severe heart failure. Methods: From October 2014 to October 2016, a total of 170 cases of elderly patients with severe heart failure (HF) in our hospital were included. According to the follow-up of 6 months after discharge whether occurring MACCE, they were divided into MACCE group (n=60) and non-MACCE group (n=110). General clinical data and laboratory tests were compared between the two groups, and the relationship between PLR and MACCE was analyzed using Logistic regression equation analysis. Results: Proportion of history of atrial fibrillation, SBP, TG, LDL-C, BNP, CRP of MACCE group were higher than those of non-MACCE group meanwhile LVEF of MACCE group was lower than that of non-MACCE group, the differences between the two groups were statistically significant(P<0.05); Platelet counts(PLT) and PLR of the MACCE group on admission or at discharge were higher than those of non-MACCE group meanwhile lymphocyte count was lower than that of non-MACCE group, the differences between the two groups were statistically significant(P<0.05); The total incidence of MACCE from A1 to A4, from B1 to B4, was increased, and the total incidence of the four groups was statistically different(χ2=29.214, P<0.001); Pearson correlation analysis showed that PLR level on admission or at discharge were positively correlated with BNP and CRP (P<0.05), while PLR was negatively correlation with LVEF (P<0.05). Logistic regression analysis also showed that PLR was recent independent risk factor for MACCE in elderly patients with severe HF (On admission: OR=2.421, 95%CI: 1.520~3.476, P<0.05; At discharge: OR=2.085, 95%CI: 1.494~3.485, P<0.05). The ROC curve analysis showed that PLR level on admission predicted the area under the curve of MACCE (AUC) was 0.840, optimal diagnostic intercept value was 132.58, and the sensitivity and specificity were 89.8% and 62.8% respectively. PLR level at discharge predicted the AUC was 0.812, optimal diagnostic intercept value was 116.45, and the sensitivity and specificity were 84.6% and 57.9% respectively. Conclusion: High levels of PLR may be the risk factor of MACCE in elderly patients with severe HF, and has certain prediction value, and the predicted value on admission is slightly higher than that at discharged. Clinical attention should to be pained in closely monitoring PLR level, in order to evaluate the prognosis of patients with early.
|
Received: 07 August 2017
|
|
|
|
[1]Burkhoff D, Maurer MS, Joseph SM, et al. Left atrial decompression pump for severe heart failure with preserved ejection fraction: theoretical and clinical considerations [J]. JACC Heart Fail, 2015, 3(4):275-282.
[2]Campana M, Scotti C, Domenighini D, et al. Serial echocardiographic examinations and prognosis in patients with severe heart failure[J]. European Journal of Heart Failure, 2015, 2(S1):111.
[3]Palau P, Domínguez E, Núez E, et al. Six-minute walk test in moderate to severe heart failure with preserved ejection fraction: Useful for functional capacity assessment[J]. Int J Cardiol, 2016, 203:800-802.
[4]中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南(2014) [J]. 中华心血管病杂志, 2014, 42(2): 98-122.
[5]Ghaffari S, Nadiri M, Pourafkari L, et al. The predictive Value of Total Neutrophil Count and Neutrophil/Lymphocyte Ratio in Predicting Inhospital Mortality and Complications after STEMI[J]. J Cardiovasc Thorac Res, 2014, 6(1): 35-41.
[6]魏新考, 李亚昭, 崔利锋. 糖皮质激素辅助治疗对重症心力衰竭患者心功能及血浆皮质醇、脑钠肽的影响[J]. 医学综述, 2017, 23(3):581-584.
[7]Eschalier R , Chenaf C, Mulliez A, et al. Impact of clinical characteristics and management on the prognosis of unselected heart failure patients [J]. Cardiovasc Drugs Ther, 2015, 29(1):89-98.
[8]Kurtul A, Murat SN, Yarlioglues M, et al. Association of platelet-to-lymphocyte ratio with severity and complexity of coronary artery disease in patients with acute coronary syndromes[J]. Am J Cardiol, 2014, 114(7): 972-978.
[9]黄冠华, 闫旭龙, 王增帅. 血小板与淋巴细胞比值与冠心病患者经皮冠状动脉介入治疗术后预后的关系研究[J]. 中国全科医学, 2016(12):33-35. 没有
[10]Osadnik T, Wasilewski J, Lekston A, et al. The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation [J]. J Saudi Heart Assoc, 2015, 27(3):144-151.
[11]Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long termmajor adverse cardiovascular events in ST-segment elevation myocardial infarction [J]. Angiology, 2016, 67( 4) : 336-345.
[12]Balci KG, Balci MM, Arslan U, et al. Increased Platelet-to-Lymphocyte Ratios and Low Relative Lymphocyte Counts Predict Appropriate Shocks in Heart Failure Patients with ICDs[J]. Acta Cardiol Sin, 2016, 32(5):542-549.
[13]Trofimov ES, Poskrebysheva AS. Study on activity of inflammatory factors in patients with chronic heart failure depending on the stage of the disease and NYHA class [J]. Bull Exp Biol Med, 2015, 158(5):614-616.
[14]Canada MN, Fronk DT, Cei LF, et al. Usefulness of C-Reactive Protein Plasma Levels to Predict Exercise Intolerance in Patients With Chronic Systolic Heart Failure[J]. Am J Cardiol, 2016, 117(1):116-120.
[15]迪丽达尔·希力甫, 阿米娜·阿迪力, 赵龙,等. 老年慢性心衰患者高尿酸血症及高凝状态的相关性分析[J]. 新疆医科大学学报, 2015, 38(8):999-1001.
[16]Mongirdiene A, Kursvietiene L, Kasauskas A. The coagulation system changes in patients with chronic heart failure [J]. Medicina (Kaunas) , 2010, 46(9):642-647.
[17]Yan W, Liu C, Li R, et al. Usefulness of the Neutrophil-to-Lymphocyte Ratio in Predicting Adverse Events in Elderly Patients With Chronic Heart Failure[J]. Int Heart J, 2016, 57(5):615-621.
[18]Wiwanitkit V. Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Heart Failure[J]. Arq Bras Cardiol, 2016, 106(3):265. |
|
|
|